Parathyroid hormone analogues in the treatment of osteoporosis

The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1

(2011) Davide Gatti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis

(2010) Julie Satterwhite et al.   CALCIFIED TISSUE INTERNATIONAL

Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS

(2010) George Lyritis et al.   CURRENT MEDICAL RESEARCH AND OPINION

Treatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study

(2010) José R. Zanchetta et al.   CURRENT MEDICAL RESEARCH AND OPINION

Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis

(2010) Jean-Yves Reginster   DRUGS

PTH analogues and osteoporotic fractures

(2010) Harald JJ Verhaar et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms

(2010) Robert L Jilka et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis

(2010) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

(2010) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?

(2010) P. D. Miller et al.   OSTEOPOROSIS INTERNATIONAL

Cellular mechanisms of bone remodeling

(2010) Erik Fink Eriksen   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

PTH-analogs: Comparable or different?

(2009) H.J.J. Verhaar et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)

(2009) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis

(2009) Athanasios D. Anastasilakis et al.   CLINICAL ENDOCRINOLOGY

Effects of Teriparatide Retreatment in Osteoporotic Men and Women

(2009) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women

(2009) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Of mice and men: divergent risks of teriparatide-induced osteosarcoma

(2009) V. Subbiah et al.   OSTEOPOROSIS INTERNATIONAL

Clinical update on teriparatide

(2009) Elizabeth File et al.   Current Rheumatology Reports

Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts

(2008) Robert L. Jilka et al.   BONE

On the Interpretation of Rat Carcinogenicity Studies for Human PTH(1-34) and Human PTH(1-84)

(2008) Armen H Tashjian et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

(2008) Barbara M Obermayer-Pietsch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*

(2008) Richard Eastell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate

(2008) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between duration of teriparatide therapy and clinical outcomes in postmenopausal women with osteoporosis

(2008) R. Lindsay et al.   OSTEOPOROSIS INTERNATIONAL

Safety of parathyroid hormone for the treatment of osteoporosis

(2008) Paul D. Miller   Current Osteoporosis Reports

The cell biology of parathyroid hormone in osteoblasts

(2008) Stavroula Kousteni et al.   Current Osteoporosis Reports

Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis

(2007) Steven Boonen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone Mass Continues to Increase at the Hip After Parathyroid Hormone Treatment Is Discontinued in Glucocorticoid-Induced Osteoporosis: Results of a Randomized Controlled Clinical Trial

(2006) Nancy E. Lane et al.   JOURNAL OF BONE AND MINERAL RESEARCH